Prostate Specific Antigen (PSA) is the most commonly used serum marker for prostate
cancer (PCa), although it is not specific and sensitive enough to allow the differential …

BACKGROUND Prostate‐specific antigen (PSA) is the tumor marker currently used for
prostate cancer (PCa) screening and diagnosis. However, its use is controversial as serum …

OBJECTIVES: To give an overview on PSA isoforms that might help to improve specificity in
Prostate Cancer (PCa) diagnosis. METHODS: The authors review all the recent papers …

Serum levels of prostate specific antigen (PSA) are commonly used for prostate cancer
(PCa) detection. However, their lack of specificity to distinguish benign prostate pathologies …

Objectives To evaluate the current role of PSA as a diagnostic method for prostate cancer,
as well as to analyze possible new markers. Methods We perform a bibliographic review for …

The introduction of prostate-specific antigen (PSA) revolutionized prostate cancer (PCa)
screening and ushered the PSA era. However, its use as a screening tool remains …

INTRODUCTION: Due to its universal applicability for early detection and prediction of
cancer stage and disease recurrence, widespread implementation of serum-based prostate …

The detection of prostate cancer using a blood test has by many standards changed the face
of the disease. Despite this tremendous success, there are limitations attributed to the use of …

Prostate-specific antigen (PSA) is one of the most widely used tumor markers, and strongly
correlates with the risk of harboring from prostate cancer (PCa). This risk is visible already …

Objectives To prospectively test the diagnostic accuracy of the percentage of prostate
specific antigen (PSA) isoform [–2] pro PSA (% p2 PSA) and the Prostate Health Index (PHI) …